PDF
ePub
Citation
Print
Abstract
Despite the fact that pharmacotherapy depressive disorders have proven efficacy, a substantial number of patients are resistant to conventional management. As neuroscientific research about pathophysiology of depression have accumulated, repeated transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) have emerged as an important mechanism-based treatment modality. This overview provides a review of therapeutic application of rTMS and tDCS in patients with depression. The clinical and basic studies of rTMS and tDCS in depression were reviewed and integrated using a literature review and interview with experts. rTMS is a noninvasive procedure of a localized pulsed magnetic field to the surface of the head to cause a depolarization of neurons in the brain cortex. tDCS has a mechanism of modulating cortical excitability in a polarity-specific manner without eliciting action potentials. rTMS and tDCS seem promising for treating depression. Although therapeutic parameters and further technical improvement remain to be systematically investigated, rTMS and tDCS would be a safe and effective intervention to treat depression.
REFERENCES
1). American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed.Arlington: American Psychiatric Publishing;2013.
2). Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. disease burden and principles of care. Can J Psychiatry. 2016; 61:510–523.
3). Fagot JP, Cuerq A, Samson S, Fagot-Campagna A. Cohort of one million patients initiating antidepressant treatment in France: 12-month followup. Int J Clin Pract. 2016; 70:744–751.
4). Sinyor M, Schaffer A, Levitt A. The sequenced treatment alternatives to relieve depression (STAR∗D) trial: a review. Can J Psychiatry. 2010; 55:126–135.
5). Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol. 2002; 53:545–574.
6). Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry. 2007; 61:198–209.
7). Erk S, Mikschl A, Stier S, Ciaramidaro A, Gapp V, Weber B, et al. Acute and sustained effects of cognitive emotion regulation in major depression. J Neurosci. 2010; 30:15726–15734.
8). Holtzheimer PE 3rd, Kosel M, Schlaepfer T. Brain stimulation therapies for neuropsychiatric disease. Handb Clin Neurol. 2012; 106:681–695.
9). Chae JH, Pae CU, Bahk WM, Jun T, Kim KS, George MS. [Application of vagus nerve stimulation in neuropsychiatry]. J Korean Neuropsychiatr Assoc. 2001; 40:371–380.
10). Zhou C, Zhang H, Qin Y, Tian T, Xu B, Chen J, et al. A systematic review and metaanalysis of deep brain stimulation in treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 82:224–232.
11). Chae JH, Jun T. [Transcranial magnetic stimulation in neuropsychiatry]. J Korean Neuropsychiatr Assoc. 2001; 40:3–11.
12). Chae JH, Lee CU, Bahk WM. [Therapeutic application of transcranial magnetic stimulation (TMS) in depression]. Korean J Psychopharmacol. 2003; 14:77–83.
13). Min JA, Lee SY, Lee CU, Chae JH. Psychiatric application of transcranial direct current stimulation (tDCS). Clin Psychopharmacol Neurosci. 2010; 8:117–126.
14). Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of the human motor cortex. Lancet. 1985; 1:1106–1107.
15). neurostar.com [homepage on the Internet]. Malvern: Neuronetics, Inc.; [cited 2018 Apr 30]. Available from:. https://neurostar.com.
16). remed.kr [homepage on the Internet]. Daejeon: Remed, Inc.; [cited 2018 Apr 30]. Available from:. http://www.remed.kr.
17). Belmaker RH, Grisaru N. Magnetic stimulation of the brain in animal depression models responsive to ECS. J ECT. 1998; 14:194–205.
18). Kim EJ, Kim WR, Chi SE, Lee KH, Park EH, Chae JH, et al. Repetitive transcranial magnetic stimulation protects hippocampal plasticity in an animal model of depression. Neurosci Lett. 2006; 405:79–83.
19). Meille V, Verges B, Lalanne L, Jonval L, Duvillard L, Chavet-Gelin-ier JC, et al. Effects of transcranial magnetic stimulation on the hypothalamic-pituitary axis in depression: results of a pilot study. J Neuropsychiatry Clin Neurosci. 2017; 29:70–73.
20). Fidalgo TM, Morales-Quezada JL, Muzy GS, Chiavetta NM, Mendonca ME, Santana MV, et al. Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review. J ECT. 2014; 30:47–61.
21). Stokes MG, Chambers CD, Gould IC, English T, McNaught E, McDonald O, et al. Distance-adjusted motor threshold for transcranial magnetic stimulation. Clin Neurophysiol. 2007; 118:1617–1625.
22). Speer AM, Kimbrell TA, Wassermann EM, D Repella J, Willis MW, Herscovitch P, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000; 48:1133–1141.
23). Nahas Z, Lomarev M, Roberts DR, Shastri A, Lorberbaum JP, Teneback C, et al. Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry. 2001; 50:712–720.
24). Richieri R, Jouvenoz D, Verger A, Fiat P, Boyer L, Lançon C, et al. Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study. Eur J Nucl Med Mol Imaging. 2017; 44:1051–1055.
25). Bickford RG, Guidi M, Fortesque P, Swenson M. Magnetic stimulation of human peripheral nerve and brain: response enhancement by combined magnetoelectrical technique. Neurosurgery. 1987; 20:110–116.
26). Höflich G, Kasper S, Hufnagel A, Ruhrmann S, Möller HJ. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression- a report of two cases. Hum Psychopharmacol. 1993; 8:361–365.
27). Grisaru N, Yaroskavsky U, Abarbanel J, Lamberg T, Belmaker RH. Transcranial magnetic stimulation in treatment of depression and schizophrenia. Eur Neuropsychopharmacol. 1994; 4:287–288.
28). Kolbinger HM, Höflich G, Hufnagel A, Möller HJ, Kasper S. Transcranial magnetic stimulation (TMS) in the treatment of major depression: a pilot study. Hum Psychopharmacol. 1995; 10:305–310.
29). Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 1989; 46:243–250.
30). Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med. 1995; 25:247–261.
31). Pascual-Leone A, Rubio B, Pallardó F, Catalá MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996; 348:233–237.
32). George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry. 1997; 154:1752–1756.
33). Berman RM, Narasimhan M, Sanacora G, Miano AP, Hoffman RE, Hu XS, et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry. 2000; 47:332–337.
34). Padberg F, Zwanzger P, Thoma H, Kathmann N, Haag C, Greenberg BD, et al. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res. 1999; 88:163–171.
35). Loo C, Mitchell P, Sachdev P, McDarmont B, Parker G, Gandevia S. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry. 1999; 156:946–948.
36). Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry. 1999; 56:315–320.
37). Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999; 46:1603–1613.
38). O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007; 62:1208–1216.
39). George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010; 67:507–516.
40). Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Pérez V, Ku-lisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and metaanalysis. Br J Psychiatry. 2003; 182:480–491.
41). Chen J, Zhou C, Wu B, Wang Y, Li Q, Wei Y, et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a metaanalysis of randomised controlled trials. Psychiatry Res. 2013; 210:1260–1264.
42). Stikhina NIa. Lyskov EB, Lomarev MP, Aleksanian ZA, Mikhaĭlov VO, Medvedev SV. [Transcranial magnetic stimulation in neurotic depression]. Zh Nevrol Psikhiatr Im S S Korsakova. 1999; 99:26–29.
43). Health Quality Ontario. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis of randomized controlled trials. Ont Health Technol Assess Ser. 2016; 16:1–66.
44). Leggett LE, Soril LJ, Coward S, Lorenzetti DL, MacKean G, Clement FM. Repetitive transcranial magnetic stimulation for treatment-resistant depression in adult and youth populations: a systematic literature review and metaanalysis. Prim Care Companion CNS Disord [serial online] 2015 Nov [cited 2018 Apr 30];17(6). Available from:. https://doi.org/10.4088/PCC.15r01807.
45). Teng S, Guo Z, Peng H, Xing G, Chen H, He B, et al. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: session-dependent efficacy: a metaanalysis. Eur Psychiatry. 2017; 41:75–84.
46). Chae JH, Nahas Z, Li X, George MS. Transcranial magnetic stimulation in psychiatry: research and therapeutic application. Int Rev Psychiatry. 2001; 13:18–23.
47). Chae JH, Kim W, Bahk WM, Jun TY, Kim KS. Repeated transcranial magnetic stimulation (rTMS) with circular coil for patients with treatment resistant depression: an open trial. Psychiatry Investig. 2005; 2:61–65.
48). Kozel FA, Nahas Z, deBrux C, Molloy M, Lorberbaum JP, Bohning D, et al. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J Neuropsychiatry Clin Neurosci. 2000; 12:376–384.
49). Nahas Z, Teneback CC, Kozel A, Speer AM, DeBrux C, Molloy M, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci. 2001; 13:459–470.
50). Herwig U, Schönfeldt-Lecuona C, Wunderlich AP, von Tiesenhau-sen C, Thielscher A, Walter H, et al. The navigation of transcranial magnetic stimulation. Psychiatry Res. 2001; 108:123–131.
51). Gugino LD, Romero JR, Aglio L, Titone D, Ramirez M, Pascual-Leone A, et al. Transcranial magnetic stimulation coregistered with MRI: a comparison of a guided versus blind stimulation technique and its effect on evoked compound muscle action potentials. Clin Neurophysiol. 2001; 112:1781–1792.
52). Loo CK, Mitchell PB, Croker VM, Malhi GS, Wen W, Gandevia SC, et al. Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychol Med. 2003; 33:33–40.
53). Fitzgerald PB, Hoy KE, Singh A, Gunewardene R, Slack C, Ibrahim S, et al. Equivalent beneficial effects of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in a large randomized trial in treatment-resistant major depression. Int J Neuropsychopharmacol. 2013; 16:1975–1984.
54). Dragasevic N, Potrebić A, Damjanović A, Stefanova E, Kostić VS. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study. Mov Disord. 2002; 17:528–532.
55). Razza LB, Moffa AH, Moreno ML, Carvalho AF, Padberg F, Fregni F, et al. A systematic review and metaanalysis on placebo response to repetitive transcranial magnetic stimulation for depression trials. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 81:105–113.
56). Taylor R, Galvez V, Loo C. Transcranial magnetic stimulation (TMS) safety: a practical guide for psychiatrists. Australas Psychiatry. 2018; 26:189–192.
57). Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009; 120:2008–2039.
58). Felipe RM, Ferrão YA. Transcranial magnetic stimulation for treatment of major depression during pregnancy: a review. Trends Psychiatry Psychother. 2016; 38:190–197.
59). Allen CH, Kluger BM, Buard I. Safety of transcranial magnetic stimulation in children: a systematic review of the literature. Pediatr Neurol. 2017; 68:3–17.
60). Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. neurostimulation treatments. Can J Psychiatry. 2016; 61:561–575.
61). Kedzior KK, Reitz SK, Azorina V, Loo C. Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) in the absence of maintenance treatment in major depression: a systematic review and metaanalysis of 16 double-blind, randomized, sham-controlled trials. Depress Anxiety. 2015; 32:193–203.
62). Lisanby SH. Focal brain stimulation with repetitive transcranial magnetic stimulation (rTMS): implications for the neural circuitry of depression. Psychol Med. 2003; 33:7–13.
63). Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA. Magnetic seizure therapy of major depression. Arch Gen Psychiatry. 2001; 58:303–305.
64). Lisanby SH. Update on magnetic seizure therapy: a novel form of convulsive therapy. J ECT. 2002; 18:182–188.
65). Fitzgerald PB, Hoy KE, Elliot D, McQueen S, Wambeek LE, Chen L, et al. A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression. Depress Anxiety. 2018; 35:393–401.
66). Rachid F. Safety and efficacy of theta-burst stimulation in the treatment of psychiatric disorders: a review of the literature. J Nerv Ment Dis. 2017; 205:823–839.
67). Berlim MT, McGirr A, Rodrigues Dos Santos N, Tremblay S, Martins R. Efficacy of theta burst stimulation (TBS) for major depression: an exploratory metaanalysis of randomized and sham-controlled trials. Psychiatr Res. 2017; 90:102–109.
68). Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety. 2010; 27:960–963.
69). Fitzgerald PB, Hoy KE, Elliot D, McQueen S, Wambeek LE, Daskalakis ZJ. Accelerated repetitive transcranial magnetic stimulation in the treatment of depression. Neuropsychopharmacology [serial online] 2018 Feb [cited 2018 Apr 30]. Available from:. https://doi.org/10.1038/s41386-018-0009-9.
70). Modirrousta M, Meek BP, Wikstrom SL. Efficacy of twice-daily vs once-daily sessions of repetitive transcranial magnetic stimulation in the treatment of major depressive disorder: a retrospective study. Neuropsychiatr Dis Treat. 2018; 14:309–316.
71). Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. Repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study. World J Biol Psychiatry. 2014; 15:298–306.
72). Yip AG, George MS, Tendler A, Roth Y, Zangen A, Carpenter LL. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial. Brain Stimul. 2017; 10:847–849.
73). Jin Y, Phillips B. A pilot study of the use of EEG-based synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. BMC Psychiatry. 2014; 14:13.
74). Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, et al. Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimul. 2015; 8:787–794.
75). Brunoni AR, Chaimani A, Moffa AH, Razza LB, Gattaz WF, Daskalakis ZJ, et al. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network metaanalysis. JAMA Psychiatry. 2017; 74:143–152.
76). Nongpiur A, Sinha VK, Praharaj SK, Goyal N. Theta-patterned, frequency-modulated priming stimulation enhances low-frequency, right prefrontal cortex repetitive transcranial magnetic stimulation (rTMS) in depression: a randomized, sham-controlled study. J Neuropsychiatry Clin Neurosci. 2011; 23:348–357.
77). medicalexpo.com [homepage on the Internet]. Marseille: VirtualEx-po, Inc.; [cited 2018 Apr 30]. Available from:. http://www.medicalexpo.com/.
78). Tik M, Hoffmann A, Sladky R, Tomova L, Hummer A, Navarro de Lara L, et al. Towards understanding rTMS mechanism of action: stimulation of the DLPFC causes network-specific increase in functional connectivity. Neuroimage. 2017; 162:289–296.
79). Choi KM, Jang KM, Jang KI, Um YH, Kim MS, Kim DW, et al. The effects of 3 weeks of rTMS treatment on P200 amplitude in patients with depression. Neurosci Lett. 2014; 577:22–27.
80). Lee SM, Chae JH. [Effects of transcranial magnetic stimulation on cognitive function]. Korean J Biol Psychiatry. 2016; 23:89–101.
81). Parent A. Giovanni Aldini: from animal electricity to human brain stimulation. Can J Neurol Sci. 2004; 31:576–584.
82). Albert DJ. The effect of spreading depression on the consolidation of learning. Neuropsychologia. 1966; 4:49–64.
83). Costain R, Redfearn JW, Lippold OC. A controlled trial of the therapeutic effect of polarization of the brain in depressive illness. Br J Psychiatry. 1964; 110:786–799.
84). Lippold OC, Redfearn JW. Mental changes resulting from the passage of small direct currents through the human brain. Br J Psychiatry. 1964; 110:768–772.
85). Nitsche MA, Boggio PS, Fregni F, Pascual-Leone A. Treatment of depression with transcranial direct current stimulation (tDCS): a review. Exp Neurol. 2009; 219:14–19.
86). Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000; 527 Pt 3:633–639.
87). Bindman LJ, Lippold OC, Redfearn JW. Long-lasting changes in the level of the electrical activity of the cerebral cortex produced bypolarizing currents. Nature. 1962; 196:584–585.
88). Rahman A, Reato D, Arlotti M, Gasca F, Datta A, Parra LC, et al. Cellular effects of acute direct current stimulation: somatic and synaptic terminal effects. J Physiol. 2013; 591:2563–2578.
89). Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain. 2002; 125(Pt 10):2238–2247.
90). Podda MV, Cocco S, Mastrodonato A, Fusco S, Leone L, Barbati SA, et al. Anodal transcranial direct current stimulation boosts synaptic plasticity and memory in mice via epigenetic regulation of BDNF expression. Sci Rep. 2016; 6:22180.
91). Okamoto K, Bosch M, Hayashi Y. The roles of CaMKII and F-actin in the structural plasticity of dendritic spines: a potential molecular identity of a synaptic tag? Physiology (Bethesda). 2009; 24:357–366.
92). Dent EW, Baas PW. Microtubules in neurons as information carriers. J Neurochem. 2014; 129:235–239.
93). Monai H, Ohkura M, Tanaka M, Oe Y, Konno A, Hirai H, et al. Calcium imaging reveals glial involvement in transcranial direct current stimulation-induced plasticity in mouse brain. Nat Commun. 2016; 7:11100.
94). Araque A, Navarrete M. Glial cells in neuronal network function. Philos Trans R Soc Lond B Biol Sci. 2010; 365:2375–2381.
95). Radman T, Ramos RL, Brumberg JC, Bikson M. Role of cortical cell type and morphology in subthreshold and suprathreshold uniform electric field stimulation in vitro. Brain Stimul. 2009; 2:215–228.
96). Chervyakov AV, Chernyavsky AY, Sinitsyn DO, Piradov MA. Possible mechanisms underlying the therapeutic effects of transcranial magnetic stimulation. Front Hum Neurosci. 2015; 9:303.
97). Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry. 2008; 63:369–376.
98). Brunoni AR, Ferrucci R, Bortolomasi M, Vergari M, Tadini L, Boggio PS, et al. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35:96–101.
99). Brunoni AR, Fregni F. Clinical trial design in non-invasive brain stimulation psychiatric research. Int J Methods Psychiatr Res. 2011; 20:e19–e30.
100). Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord. 2006; 8:203–204.
101). Boggio PS, Rigonatti SP, Ribeiro RB, Myczkowski ML, Nitsche MA, Pascual-Leone A, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol. 2008; 11:249–254.
102). Dedoncker J, Brunoni AR, Baeken C, Vanderhasselt MA. The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and metaanalysis. J Neural Transm (Vienna). 2016; 123:1159–1172.
103). Mulquiney PG, Hoy KE, Daskalakis ZJ, Fitzgerald PB. Improving working memory: exploring the effect of transcranial random noise stimulation and transcranial direct current stimulation on the dorsolateral prefrontal cortex. Clin Neurophysiol. 2011; 122:2384–2389.
104). Ohn SH, Park CI, Yoo WK, Ko MH, Choi KP, Kim GM, et al. Time-dependent effect of transcranial direct current stimulation on the enhancement of working memory. Neuroreport. 2008; 19:43–47.
105). Boggio PS, Bermpohl F, Vergara AO, Muniz AL, Nahas FH, Leme PB, et al. Go-no-go task performance improvement after anodal transcranial DC stimulation of the left dorsolateral prefrontal cortex in major depression. J Affect Disord. 2007; 101:91–98.
106). Wolkenstein L, Plewnia C. Amelioration of cognitive control in depression by transcranial direct current stimulation. Biol Psychiatry. 2013; 73:646–651.
107). Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF, Goulart A, et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry. 2013; 70:383–391.
108). Blumberger DM, Tran LC, Fitzgerald PB, Hoy KE, Daskalakis ZJ. A randomized double-blind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression. Front Psychiatry. 2012; 3:74.
109). Rigonatti SP, Boggio PS, Myczkowski ML, Otta E, Fiquer JT, Ribeiro RB, et al. Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur Psychiatry. 2008; 23:74–76.
110). Brunoni AR, Moffa AH, Fregni F, Palm U, Padberg F, Blumberger DM, et al. Transcranial direct current stimulation for acute major depressive episodes: metaanalysis of individual patient data. Br J Psychiatry. 2016; 208:522–531.
111). Brunoni AR, Valiengo L, Baccaro A, Zanao TA, de Oliveira JF, Vieira GP, et al. Sertraline vs. electrical current therapy for treating depression clinical trial-select TDCS: design, rationale and objectives. Contemp Clin Trials. 2011; 32:90–98.
112). Valiengo L, Benseñor IM, Goulart AC, de Oliveira JF, Zanao TA, Boggio PS, et al. The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and followup phases. Depress Anxiety. 2013; 30:646–653.
113). Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, et al. Trial of electrical direct-current therapy versus escitalopram for depression. N Engl J Med. 2017; 376:2523–2533.
114). Berlim MT, Van den Eynde F, Daskalakis ZJ. Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: a systematic review and metaanalysis of randomized, double-blind and sham-controlled trials. J Psychiatr Res. 2013; 47:1–7.
115). Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a metaanalysis. Psychol Med. 2012; 42:1791–1800.
116). Martin DM, Moffa A, Nikolin S, Bennabi D, Brunoni AR, Flannery W, et al. Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: an individual patient data metaanalysis of randomised, sham-controlled trials. Neurosci Biobehav Rev. 2018; 90:137–145.
117). Zaghi S, Acar M, Hultgren B, Boggio PS, Fregni F. Noninvasive brain stimulation with low-intensity electrical currents: putative mechanisms of action for direct and alternating current stimulation. Neuroscientist. 2010; 16:285–307.
118). Bikson M, Datta A, Elwassif M. Establishing safety limits for transcranial direct current stimulation. Clin Neurophysiol. 2009; 120:1033–1034.
119). Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol. 2011; 14:1133–1145.
120). Buckus R, Strukcinskiene B, Raistenskis J, Stukas R. Modelling and assessment of the electric field strength caused by mobile phone to the human head. Vojnosanit Pregl. 2016; 73:538–543.
121). Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, et al. Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul. 2016; 9:641–661.
122). Gupta A, Adnan M. Hypomania risk in noninvasive brain stimulation. Cureus. 2018; 10:e2204.
123). neurocare.com [homepage on the Internet]. Salem: GmbH Inc.; [cited 2018 May 2]. Available from:. http://www.neurocare.com.
124). soterixmedical.com [homepage on the Internet]. New York: Soterix Medical, Inc.; [cited 2018 May 2]. Available from:. http://www.soterixmedical.com.
125). ybrain.com [homepage on the Internet]. Seongnam: Ybrain, Inc.; [cited 2018 May 2]. Available from:. http://ybrain.com.
126). Fregni F, Nitsche MA, Loo CK, Brunoni AR, Marangolo P, Leite J, et al. Regulatory considerations for the clinical and research use of transcranial direct current stimulation (tDCS): review and recommendations from an expert panel. Clin Res Regul Aff. 2015; 32:22–35.
127). Antal A, Alekseichuk I, Bikson M, Brockmöller J, Brunoni AR, Chen R, et al. Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol. 2017; 128:1774–1809.
XML Download